Print Page

Products found to contain undeclared medicines

The United States: Public Notificaiton: “MAXILOSS Weight Advanced” contains hidden drug ingredient sibutramine
The Food and Drug Administration (FDA) is advising consumers not to purchase or use “MAXILOSS Weight Advanced”, a product promoted and sold for weight loss on various websites, including, and in some retail stores. FDA laboratory analysis confirmed that “MAXILOSS Weight Advanced” contains sibutramine. Sibutramine is a controlled substance that was removed from the US market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking. Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a healthcare professional as soon as possible.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Wednesday, January 09, 2013
Issued at HKT 12:00

Related Information:
The United States: Maxiloss Weight Advanced Softgels: Recall - Undeclared Drug I... Posted 2013-02-26